Page 20 - AN-3-3

Advanced Neurology Alzheimer’s and Parkinson’s disease rodent models

16. Mustapha M, Mat Taib CN. MPTP-induced mouse model exercise in animal models of Parkinson’s disease: A systematic
of Parkinson’s disease: A promising direction of therapeutic review. Neurosci Biobehav Rev. 2021;131:1056-1075.
strategies. Bosn J Basic Med Sci. 2021;21(4):422-433.
doi: 10.1016/j.neubiorev.2021.10.019
doi: 10.17305/bjbms.2020.5181 28. Glinka Y, Gassen M, Youdim MB. Mechanism of
17. Langston JW. The MPTP story. J Parkinsons Dis. 6-hydroxydopamine neurotoxicity. J Neural Transm Suppl.
2017;7(S1):S11-S19. 1997;50:55-66.
doi: 10.3233/JPD-179006 doi: 10.1007/978-3-7091-6842-4_7
18. Dauer W, Przedborski S. Parkinson’s disease. Neuron. 29. Kupsch A, Schmidt W, Gizatullina Z, et al.
2003;39(6):889-909. 6-Hydroxydopamine impairs mitochondrial function
in the rat model of Parkinson’s disease: Respirometric,
doi: 10.1016/S0896-6273(03)00568-3
histological, and behavioral analyses. J Neural Transm.
19. Bhurtel S, Katila N, Srivastav S, Neupane S, Choi DY. 2014;121(10):1245-1257.
Mechanistic comparison between MPTP and rotenone
neurotoxicity in mice. Neurotoxicology. 2019;71:113-121. doi: 10.1007/s00702-014-1185-3
30. Berry C, La Vecchia C, Nicotera P. Paraquat and Parkinson’s
doi: 10.1016/j.neuro.2018.12.009
disease. Cell Death Differ. 2010;17(7):1115-1125.
20. Burré J. The synaptic function of α-synuclein. J Parkinsons
Dis. 2015;5(4):699-713. doi: 10.1038/cdd.2009.217
31. Manning-Bog AB, McCormack AL, Li J, Uversky VN,
doi: 10.3233/JPD-150642
Fink AL, Di Monte DA. The herbicide paraquat causes
21. Karampetsou M, Ardah MT, Semitekolou M, et al. up-regulation and aggregation of alpha-synuclein
Phosphorylated exogenous alpha-synuclein fibrils in mice: Paraquat and alpha-synuclein. J Biol Chem.
exacerbate pathology and induce neuronal dysfunction in 2002;277(3):1641-1644.
mice. Sci Rep. 2017;7(1):16533.
doi: 10.1074/jbc.C100560200
doi: 10.1038/s41598-017-15813-8
32. McCormack AL, Thiruchelvam M, Manning-Bog AB, et al.
22. Gómez-Benito M, Granado N, García-Sanz P, Michel A, Environmental Risk factors and Parkinson’s disease: Selective
Dumoulin M, Moratalla R. Modeling Parkinson’s disease degeneration of nigral dopaminergic neurons caused by the
with the alpha-synuclein protein. Front Pharmacol. herbicide paraquat. Neurobiol Dis. 2002;10(2):119-127.
2020;11:356.
doi: 10.1006/nbdi.2002.0507
doi: 10.3389/fphar.2020.00356
33. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M,
23. Harms AS, Delic V, Thome AD, et al. α-Synuclein fibrils Panov AV, Greenamyre JT. Chronic systemic pesticide
recruit peripheral immune cells in the rat brain prior exposure reproduces features of Parkinson’s disease. Nat
to neurodegeneration. Acta Neuropathol Commun. Neurosci. 2000;3(12):1301-1306.
2017;5(1):85.
doi: 10.1038/81834
doi: 10.1186/s40478-017-0494-9
34. Innos J, Hickey MA. Using rotenone to model Parkinson’s
24. Chmielarz P, Domanskyi A. Alpha-synuclein preformed disease in mice: A review of the role of pharmacokinetics.
fibrils: A tool to understand Parkinson’s disease and Chem Res Toxicol. 2021;34(5):1223-1239.
develop disease modifying therapy. Neural Regen Res. doi: 10.1021/acs.chemrestox.0c00522
2021;16(11):2219-2221.
35. Niederberger E, Wilken-Schmitz A, Manderscheid C,
doi: 10.4103/1673-5374.310686
Schreiber Y, Gurke R, Tegeder I. Non-reproducibility of oral
25. Polinski NK, Volpicelli-Daley LA, Sortwell CE, et al. Best rotenone as a model for Parkinson’s disease in mice. Int J Mol
practices for generating and using alpha-synuclein pre- Sci. 2022;23(20):12658.
formed fibrils to model Parkinson’s disease in rodents. doi: 10.3390/ijms232012658
J Parkinsons Dis. 2018;8(2):303-322.
36. Richter F, Hamann M, Richter A. Chronic rotenone treatment
doi: 10.3233/JPD-171248
induces behavioral effects but no pathological signs of
26. Simola N, Morelli M, Carta AR. The 6-hydroxydopamine parkinsonism in mice. J Neurosci Res. 2007;85(3):681-691.
model of Parkinson’s disease. Neurotox Res. 2007;11(3- doi: 10.1002/jnr.21159
4):151-167.
37. Inden M, Kitamura Y, Takeuchi H, et al. Neurodegeneration
doi: 10.1007/BF03033565
of mouse nigrostriatal dopaminergic system induced by
27. Ferreira AFF, Binda KH, Real CC. The effects of treadmill repeated oral administration of rotenone is prevented by

Volume 3 Issue 3 (2024) 14 doi: 10.36922/an.2903